Wells Fargo analyst Joseph O’Dea lowered the firm’s price target on Emerson (EMR) to $135 from $160 and keeps an Equal Weight rating on the shares. The Middle East conflict didn’t drive an elevated level of caution in most of the firm’s catch-up calls. But just like tariffs sidelined a PMI recovery last year, Wells is cautious that a new source of uncertainty dampens sentiment until there’s better clarity.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMR:
